Jeffrey Engelman

Massachusetts General Hospital and Harvard Medical School. Jeffrey A. Engelman is the Director of Thoracic Oncology and the Director of Molecular Therapeutics at the Massachusetts General Hospital Cancer Center and is an Associate Professor of Medicine at Harvard Medical School.Engelman is also the PI of his own laboratory at the MGH Cancer Center. The overarching aim of his research is to develop new and more potent therapeutic strategies for the treatment of cancer, with a particular emphasis on lung cancer.

Engelman completed his medical residency in Internal Medicine at Brigham and Women’s Hospital and his fellowship in Hematology and Oncology at the Dana-Farber Cancer Institute/Massachusetts General Hospital combined program. He received his MD and PhD degrees from the Albert Einstein College of Medicine and his B.A. from Northwestern University.

Jeffrey Engelman is the Member of the Scientific Advisors at Agios Pharmaceuticals. With a background in Biotechnology, Jeffrey Engelman has a rich history of leadership and innovation.Jeffrey Engelman studied MD, PhD Molecular Pharmacology at Albert Einstein College of Medicine. Explore their detailed professional journey, key connections, and contributions to the industry on our platform.